Pliego RCL, Flores AG

Language: Spanish
References: 11
Page: 35-42
PDF size: 227.65 Kb.

Text Extraction

No abstract

REFERENCES

1. NOM -003-SSA2-1993 para la disposición de sangre humana y sus componentes con fines terapéuticos.

2. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. First of two parts. Blood transfusion. N Engl J Med. 1999;340(6):438-47.

3. American Society of Anesthesiologists. Task force on blood component therapy. Practice guidelines for blood component therapy. Anesthesiology. 1996;84(3):732-47.

4. Carson L, Duff A, Poses R, et al. Effect of anemia and cardiovascular disease on surgical mortality and morbility. Lancet. 1996;348:1055-60.

5. Simon TL, Alverson DC, AuBuchon J, Cooper ES, De-Christopher PJ, Glenn GC. Practice parameter for the use of red cell blood transfusions. Arch Pathol Lab Med. 1998; 122(2):130-8.

6. Marshal JC. Transfusion trigger: when to transfuse? Crit Care. 2004;8 Suppl 2:S31-3.

7. Welch H, Meehan K, Goodnough L. Prudent strategies for elective red blood cell transfusion. Ann Intern Med. 1992;116(5):393-402.

8. Shander A, Goodnough L. Why an alternative to blood transfusion?. Crit Care Clin. 2009;25(2):261-77.

9. Stroncek D, Rebulla P. Platelet transfusions. Lancet. 2007; 370:427-38.

10. Steiner M, Despotis G. Transfusion algorithms and how they apply to blood conservation: the high risk cardiac surgical patient. Hematol Oncol Clin North Am. 2007;21(1): 177-84.

11. Brooks, J. Qualitiy improvement opportunities in blood banking and transfusion medicine. Clin Lab Med. 2008;28(2): 321-37.